Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM)…
<!-- Name:DistributionId Value:8846053 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
GBM
Researchers identify a gene as a potential target in treatment-resistant brain cancer…
Research led by doctors and scientists at UCLA Jonsson Comprehensive Cancer Center and the UCLA Jane & Terry Semel Institute for Neuroscience & Human Behavior have identified a gene…
CNS Pharmaceuticals Inc. Featured in Syndicated Broadcast Covering Activation of…
LOS ANGELES, Oct. 07, 2022 (GLOBE NEWSWIRE) -- InvestorWire -- CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel…
Erasca Announces FDA Clearance of IND Application for ERAS-801 in Glioblastoma…
IND filing achieved ahead of schedule; dosing of first patient in THUNDERBBOLT-1 Phase 1 clinical trial in recurrent GBM anticipated in Q1 2022 Early collaboration with GCAR could support…
IPAX-1 Late Breaking Oral Presentation at the Congress of Neurological Surgeons (CNS)…
MELBOURNE, Australia and INDIANAPOLIS, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce the first set of peer-reviewed…